BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33535429)

  • 21. Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein C expression in alveolar epithelial cells.
    Puthusseri B; Marudamuthu A; Tiwari N; Fu J; Idell S; Shetty S
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L783-L796. PubMed ID: 28385810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
    Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
    Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.
    Simon DI; Rao NK; Xu H; Wei Y; Majdic O; Ronne E; Kobzik L; Chapman HA
    Blood; 1996 Oct; 88(8):3185-94. PubMed ID: 8874219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.
    Tucker TA; Dean C; Komissarov AA; Koenig K; Mazar AP; Pendurthi U; Allen T; Idell S
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):685-96. PubMed ID: 19635932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase mediates fibrinolysis in the pulmonary microvasculature.
    Bdeir K; Murciano JC; Tomaszewski J; Koniaris L; Martinez J; Cines DB; Muzykantov VR; Higazi AA
    Blood; 2000 Sep; 96(5):1820-6. PubMed ID: 10961882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation.
    Del Rosso M; Margheri F; Serratì S; Chillà A; Laurenzana A; Fibbi G
    Curr Pharm Des; 2011; 17(19):1924-43. PubMed ID: 21711238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolytic and inflammatory processes in pleural effusions.
    Philip-Joët F; Alessi MC; Philip-Joët C; Aillaud M; Barriere JR; Arnaud A; Juhan-Vague I
    Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.
    Shetty S; Padijnayayveetil J; Tucker T; Stankowska D; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L967-75. PubMed ID: 18836029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
    Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
    J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H; Vaheri A
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.
    East E; Baker D; Pryce G; Lijnen HR; Cuzner ML; Gverić D
    Am J Pathol; 2005 Aug; 167(2):545-54. PubMed ID: 16049338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
    Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.